Home / News / CMS advises ST Pharm on dual pharma acquisitions

CMS advises ST Pharm on dual pharma acquisitions

27 November 2019

International law firm CMS has advised ST Pharm Co. Ltd., a major Korean pharmaceuticals manufacturer, on two complex and interconnected acquisitions. 

The cross-jurisdictional CMS team, led from Singapore and including teams from Spain and Switzerland, assisted ST Pharm in acquiring a 70% stake in Swiss contract laboratory services and histopathology company, AnaPath Services, whilst simultaneously advising AnaPath Services on its 100% acquisition of Spanish contract research organisation, Envigo CRS. 

With the completion of the acquisition of these two companies, ST Pharm intends to launch a new business line focused on medical testing and analysis. 

CMS Singapore

  • Toby Grainger
  • Charlotte Holder 
  • Pamela Chan 
  • Eric Lai
  • Alex Gewanter

CMS Switzerland

  • Stefan Brunnschweiler 
  • Andrea Relly
  • Miryam Meile

CMS Spain

  • Jose Maria Roji Buqueras 
  • Guillermo Donadeu
  • Jorge Prada
  • Alejandro Gil Murillo
  • Pedro Ferreras


Related people

Portrait of Toby Grainger
Toby Grainger
Managing Partner
Portrait of Alex Gewanter
Alex Gewanter
Portrait of Stefan Brunnschweiler
Stefan Brunnschweiler, LL.M.
Managing Partner
Portrait of Andrea Relly
Andrea Relly
Portrait of José María Rojí
José María Rojí
Portrait of Pedro Ferreras
Pedro Ferreras
Charlotte Holder
Pamela Chan
Dr Miryam Meile
Guillermo Donadeu
Senior Associate
Jorge Prada
Alejandro Gil Murillo
Eric Lai
Show more Show less